Page last updated: 2024-09-05

tak 779 and tak-220

tak 779 has been researched along with tak-220 in 3 studies

Compound Research Comparison

Studies
(tak 779)
Trials
(tak 779)
Recent Studies (post-2010)
(tak 779)
Studies
(tak-220)
Trials
(tak-220)
Recent Studies (post-2010) (tak-220)
118135803

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)tak-220 (IC50)
C-C chemokine receptor type 5Homo sapiens (human)0.002

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, M; Miyake, H; Okamoto, M; Takashima, K; Wang, X1
Fujisawa, J; Furuta, RA; Kanzaki, N; Nishi, T; Nishikawa, M; Takashima, K; Yamamoto, Y1
Dioszegi, M; Ji, C; Kondru, R; Mirzadegan, T; Rotstein, D; Sankuratri, S; Zhang, J1

Other Studies

3 other study(ies) available for tak 779 and tak-220

ArticleYear
Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Amino Acid Sequence; Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Cytopathogenic Effect, Viral; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Imidazoles; Leukocytes, Mononuclear; Molecular Sequence Data; Sulfoxides; Virus Replication

2007
Analysis of binding sites for the new small-molecule CCR5 antagonist TAK-220 on human CCR5.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11

    Topics: Amides; Amino Acid Sequence; Anti-HIV Agents; Binding Sites; CCR5 Receptor Antagonists; HIV-1; Humans; Models, Molecular; Molecular Sequence Data; Mutation; Piperidines; Quaternary Ammonium Compounds; Receptors, CCR5

2005
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Molecular pharmacology, 2008, Volume: 73, Issue:3

    Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; Benzoates; Binding Sites; CCR5 Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Maraviroc; Membrane Fusion; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Piperazines; Piperidines; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Spiro Compounds; Static Electricity; Transfection; Triazoles

2008